5 Use Cases for Commercial Pharma AI Beyond Drug Discovery

JACOB VAZQUEZ | February 11, 2019

article image
Artificial Intelligence, or AI for short, has been one of those buzzwords that’s been circulating throughout the healthcare industry. Most recently, it has been widely considered to be extremely beneficial for drug discovery and in clinical trials. However, that’s just a very small aspect of the total benefit that pharma AI can bring to the table for the pharma and biotech industries.

Spotlight

United Medical Devices

Playboy Condoms launched in 2010 and has seen the fastest growth in the condom segment out of any other brand. Since the launch, Playboy Condoms has secured distribution in over 80 countries around the world and our products are now on the shelves of major convenience stores and pharmacies in over 30 countries, with the number of retailers increasing by the quarter, with many more almost through local health requirements to receive goods. Since the launch of Playboy Condoms, we have doubled our world wide shipments of containers year over year.

OTHER ARTICLES

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | April 10, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 10, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | April 10, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Spotlight

United Medical Devices

Playboy Condoms launched in 2010 and has seen the fastest growth in the condom segment out of any other brand. Since the launch, Playboy Condoms has secured distribution in over 80 countries around the world and our products are now on the shelves of major convenience stores and pharmacies in over 30 countries, with the number of retailers increasing by the quarter, with many more almost through local health requirements to receive goods. Since the launch of Playboy Condoms, we have doubled our world wide shipments of containers year over year.

Events